COPD - Positive Results Of Seretide Survival Study
Tue, 28 Mar 2006 11:00 PM EST
... GlaxoSmithKline plcannounces preliminary results from the TORCH study (TOwards a Revolution inCOPD Health) which show a 17% relative reduction in mortality over three yearsfor patients receiving Seretide(TM) 50/500 micrograms (EU) /Advair(R) (US)(salmeterol/fluticasone propionate) as compared with patients on placebo(p=0... click link for more info. ...
Related Topics
- COPD (Chronic Obstructive Pulmonary Disease)
- Tb
- CHF
- Urinalysis
- Chronic Obstructive Pulmonary Disease (COPD)
- Radiation Studies
- Esophageal Cancer
- Premature Babies
- HLA-B27
- Triple Screen
- Kidney Cancer
- Myeloma, Multiple
- Multiple Myeloma
- Non-Hodgkin's Lymphoma
- TB Skin Test
- Ovarian Cancer
- PET Study
- Caregiving
- Hodgkin's Lymphoma
- Tiotropium bromide

Not Signed In -


